N
Minerva Neurosciences D
D
NERV
2.27000
USD
0.46
(25.41%)
مغلق
حجم التداول
1,750
الربح لكل سهم
-3
العائد الربحي
-
P/E
3
حجم السوق
15,875,032
الأخبار المقالات
العنوان: Minerva Neurosciences
القطاع: Healthcare
الصناعة: Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.